Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure

Arthritis and Rheumatism
Robert B ZurierS Burstein

Abstract

To assess the antiinflammatory activity of dimethylheptyl-THC-11 oic acid (DMH-11C), a nonpsychoactive synthetic derivative of tetrahydrocannabinol. Acute inflammation was induced by injection of interleukin-1beta and tumor necrosis factor alpha into subcutaneous air pouches formed on the backs of mice. Inflammation was quantified 6 hours later by pouch fluid leukocyte counts. Adjuvant-induced polyarthritis in rats was used as a model of chronic inflammation and joint tissue injury. Animals were either untreated, treated with safflower oil, or treated with DMH-11C in safflower oil. Arthritis was assessed by clinical observation and by histomorphologic evaluation of tibiotarsal joints. Oral administration of DMH-11C reduced the accumulation of pouch fluid leukocytes and significantly reduced the severity of adjuvant-induced polyarthritis. Histopathologic studies of tibiotarsal joints showed that DMH-11C treatment attenuated pannus formation and joint tissue injury. DMH-11C suppresses acute inflammation in the subcutaneous air pouch in mice and chronic joint inflammation characteristic of adjuvant disease in rats. These results demonstrate the potential use of this nonpsychoactive cannabinoid as an antiinflammatory agent.

References

May 8, 1991·Biochimica Et Biophysica Acta·D L DeWitt
Sep 1, 1991·Arthritis and Rheumatism·C E Brinckerhoff
Aug 1, 1990·Agents and Actions·S A DoyleS P Welch
Nov 1, 1988·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S H BursteinV Latham
Jan 1, 1988·Methods in Enzymology·J D TaurogR A McReynolds
Nov 1, 1973·Journal of Medicinal Chemistry·B LoevP J Fowler
Mar 17, 1995·Biochemical and Biophysical Research Communications·S Arias-NegreteK Chadee
Sep 1, 1995·American Journal of Therapeutics·Ronald G. RossettiRobert B. Zurier

❮ Previous
Next ❯

Citations

Sep 12, 2001·Biochemical Pharmacology·L D RechtS Burstein
Feb 13, 2001·Progress in Neurobiology·R G Pertwee
Aug 19, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Bonnie BidingerRobert B Zurier
Jan 7, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Robert B ZurierCharles N Serhan
Nov 16, 2006·The Journal of Pharmacology and Experimental Therapeutics·Robert E VannJenny L Wiley
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Feb 22, 2008·PPAR Research·Yan Sun, Andy Bennett
May 12, 2012·Mediators of Inflammation·Luciano S A CapettiniFabrizio Montecucco
Feb 10, 2009·The AAPS Journal·Sumner H Burstein, Robert B Zurier
Jul 2, 2011·Biological & Pharmaceutical Bulletin·Takashi TanikawaYasuyuki Imai
Mar 2, 2010·Future Medicinal Chemistry·Prakash NagarkattiMitzi Nagarkatti
Apr 26, 2012·Future Medicinal Chemistry·Sara L DunnRowena A D Bunning
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·A M MalfaitM Feldmann
Nov 27, 2009·Expert Opinion on Therapeutic Patents·Ganesh A ThakurAlexandros Makriyannis
Feb 16, 2016·Autoimmunity Reviews·Valeria KatchanYehuda Shoenfeld
Jul 12, 2005·Expert Opinion on Investigational Drugs·Alyson Fox, Stuart Bevan
May 22, 2009·Immunobiology·Sadiye Amcaoglu RiederPrakash Nagarkatti
Feb 6, 2014·The European Journal of Neuroscience·Carmen La PortaRafael Maldonado
Jul 9, 2004·Life Sciences·Sumner H BursteinRobert B Zurier
Jun 1, 2005·Neuroscience Letters·Vanessa A MitchellChristopher W Vaughan
Feb 2, 2006·The Annals of Pharmacotherapy·Tammy L Burns, Joseph R Ineck
Oct 31, 2002·Human Psychopharmacology·Gabriel G NahasKenneth M Sutin
Apr 12, 2018·Pharmacology Research & Perspectives·Sumner H Burstein
Dec 15, 2017·Clinical Pharmacology and Therapeutics·Madhur P MotwaniDerek W Gilroy
Aug 24, 2006·Journal of Cellular Biochemistry·David R JohnsonRobert B Zurier
Aug 23, 2007·Chemistry & Biodiversity·Barbara Costa
Nov 28, 2007·Rheumatology International·Jennifer ParkerRobert B Zurier
May 3, 2005·Nature Reviews. Immunology·Thomas W Klein
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Thomas W Klein, Guy A Cabral
Sep 1, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Giulia DonvitoAron H Lichtman
Jul 4, 2019·Clinical Reviews in Allergy & Immunology·Fereshte AbdolmalekiAmirhossein Sahebkar
Nov 3, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Robert B Zurier, Sumner H Burstein
Jan 18, 2003·Journal of Cellular Biochemistry·Robert B Zurier
Sep 13, 2019·Expert Review of Clinical Immunology·Piercarlo Sarzi-PuttiniWinfred Hauser
Jan 1, 2016·Cannabis and Cannabinoid Research·Sara L DunnChristine L Le Maitre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here